ENFERMEDADES NEUROMUSCULARES
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (8)
2023
-
Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells
Frontiers in Cell and Developmental Biology, Vol. 11
2022
-
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies
Frontiers in Neurology, Vol. 13
-
Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model
International Journal of Molecular Sciences, Vol. 23, Núm. 7
-
Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism
Brain, Vol. 145, Núm. 6, pp. 2092-2107
2021
-
Corticosteroid-binding-globulin (CBG)deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus
PLoS ONE, Vol. 16, Núm. 2 February
2018
-
Association of lifestyle, inflammatory factors, and dietary patterns with the risk of suffering a stroke: A case–control study
Nutritional Neuroscience, Vol. 21, Núm. 1, pp. 70-78
-
Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease
Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183
2016
-
Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease
Hippocampus, Vol. 26, Núm. 10, pp. 1303-1312